pillbase.ru

Alhemo

Active substance: concizumab

concizumab

Centralised EU authorisationActive

Marketing holder: Novo Nordisk A/S

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 3
  • Alhemo
    INJECTION, SOLUTION · CONCIZUMAB 40 mg/mL
    0169-2084
    Novo Nordisk
  • Alhemo
    INJECTION, SOLUTION · CONCIZUMAB 100 mg/mL
    0169-2081
    Novo Nordisk
  • Alhemo
    INJECTION, SOLUTION · CONCIZUMAB 100 mg/mL
    0169-2080
    Novo Nordisk
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-4093-752d-9238-f64c8e761962,01a12095-c615-7190-a52b-946a339966bd,01a12098-6f20-79b2-9baf-285380e8fc5b;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005938
Registration status
Active
ATC code
B02BX10
Sources
  • product · EMA · EMEA/H/C/005938 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005938 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005938 · Verified 2026-10-09